May 07, 2012, 03.11 PM | Source: Reuters
Drugmaker Elder Pharmaceuticals is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.
One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage.
Elder Pharma Joint Managing Director Alok Saxena denied that the company was looking to sell the business.
"We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters.
The nutrition supplements market in India, home to more than 1.3 billion people, is relatively undeveloped and valued at about USD 1 billion, according to the lobby group Federation of Indian Chambers of Commerce and Industry.
A rapidly expanding middle-class, increasing incidence of diabetes and longer life spans are driving demand for nutrition products in India, an opportunity that has caught the attention of multinationals.
Last year, French drugmaker Sanofi's
Elder Pharma stock price
On February 12, 2016, Elder Pharmaceuticals closed at Rs 44.35, down Rs 2.3, or 4.93 percent. The 52-week high of the share was Rs 138.00 and the 52-week low was Rs 44.35.
The latest book value of the company is Rs 382.51 per share. At current value, the price-to-book value of the company was 0.12.
Elder Pharmaceuticals' board meeting on February 03, 2016
Elder Pharmaceuticals Ltd has informed BSE that a
Elder Pharma appoints Ravani Mohammed Abdul as additional directors
Elder Pharmaceuticals has informed that the Promot
Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspection
Hold Torrent Pharma; target of Rs 1560: Religare
Religare has recommended hold rating on Torrent Ph
Buy Aurobindo Pharma;target of Rs 940: Axis Securities
Axis Securities is bullish on Aurobindo Pharma has
Sun Pharma Q3 beats estimates, profit jumps 28%; revenue up 3.6%
Revenue increased 3.6 percent to Rs 7,082 crore in
Buy Aurobindo Pharma; target of Rs 905: Emkay
Emkay is bullish on Aurobindo Pharma and has recom
Source Natural standalone Dec '15 sales at Rs 2.89 crore
Source Natural Foods and Herbal Supplements has re